Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Spectrum Pharma: Expect a Positive FDA Decision
- Spectrum Pharma has a new article on BioMedReports.com. The article states that a decision on SPPI's SPPI drug Zevalin should have a decision made on September 7th. The article tagged Spectrum Pharma can be found here. This is good news for investors looking for the next breakout stock. The stock...
- External links 2009-08-23
- Is It Worth Investing in the Merck / Schering Merger Now?
- I was doing some homework on the Merck MRK - Schering SGP merger and thought what would you make if the deal took place today. Merck and Schering-Plough expect to complete the transaction in the fourth quarter of 2009. The details of the merger states for every 1 share Schering,...
- External links 2009-08-23
- Novartis Gets $690 Million H1N1 Vaccine Order
- Swiss company Novartis (NYSE: NVS) received an order for $346 million for antigen and $343.8 million for adjuvant totalling $690 million in July. Currently, Novartis is building a vaccine facility in Holly Springs and is hiring right now for validating the buildings and getting them up and running. So there...
- External links 2009-08-24
- Human Genome Sciences Jumps on Glaxo Takeover Rumors
- Rumors of Glaxo's GSK takeover of Human Genome Sciences HGSI for $30/share have pushed the stock up considerably Tuesday. Human Genome Sciences stock was up $2.03 to $19.21 per share in afternoon trading with a gain of 11.79%. Aftermarket trading is up +0.46 to 19.66, another gain of 2.40%. I...
- External links 2009-08-26
- Vivus's Qnexa Drug Approval Makes It a Nice Trade
- Here are Wednesday's articles concerning Vivus Inc's VVUS FDA approval for Qnexa. I see this as a blockbuster drug candidate and good news for the nearly 40M Obese Americans. My only caution is later health problems as it uses some form of the fen-phen medication. This is a nice trade...
- External links 2009-09-10
- Jazz and Transcept Pharmaceuticals on the Rise
- Two stocks of note in the past week are Jazz Pharmaceuticals JAZZ and Transcept Pharmaceuticals TSPT. Last week, Transcept attended the BioCentury Thomson Reuters Newsmakers in the Biotechnology Industry Conference on Sept 16, 2009. Jazz was also in attendance. It seems this conference is playing out as stocks have risen...
- External links 2009-09-24
Additional Resources
- PDL BioPharma Q4 2005 Earnings Conference Call Transcript (PDLI)
- Earnings Call Excerpt PDL BioPharma Q4 2005 Results Conference Call PDLI February 27, 2006 Executives Ami Knoefler, Sr. Director Corporate Investor Relations Mark McDade, Chief Executive Officer Steven Benner, Chief Medical Officer Analysts Bret Holley, CIBC World Markets Eric Hoffman,...
- Earnings calls 2006-02-28
- AVI BioPharma, T-NETIX, Elcor, Fischer Imaging and American Homestar Conference Calls to be Broadcast On Investor Broadcast Network Over the Internet
- Business Editors/Hi-Tech Writers Philadelphia - AVI BioPharma Inc. (Nasdaq: AVII), T-NETIX, Inc. (Nasdaq: TNTX), Elcor Corporation (NYSE: ELK), Fischer Imaging Corporation (Nasdaq: FIMG), and American Homestar Corporation (Nasdaq: HSTR) will broadcast their investor communication conference calls over the Internet, Investor Broadcast Network announced. AVI BioPharma Inc. will broadcast...
- Research articles 2000-08-11
- PDL BioPharma Announces Participation at Upcoming Lazard Investor Conference and Amylin Pharmaceuticals to Present at Piper Jaffray Healthcare Conference.
- M2 PRESSWIRE-27 November 2006-U.S. Equity News: PDL BioPharma Announces Participation at Upcoming Lazard Investor Conference and Amylin Pharmaceuticals to Present at Piper Jaffray Healthcare ConferenceC1994-2006 M2 COMMUNICATIONS LTD RDATE:27112006 City of Industry, CA - Biotechnology industry alert provided by U.S....
- Research articles 2006-11-27
- Inspire Announces CEO to Present at Investor Conference and Array BioPharma to Report Financial Results.
- M2 PRESSWIRE-9 February 2005-FNWU: Inspire Announces CEO to Present at Investor Conference and Array BioPharma to Report Financial ResultsC1994-2005 M2 COMMUNICATIONS LTD RDATE:02092005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). Inspire Pharmaceuticals, Inc....
- Research articles 2005-02-09
- AVI BioPharma Executives to Speak at Roth Capital Partners and BIO CEO Investor Conferences
- Business Editors, Health/Medical Writers BIO CEO and Investor Conference 2002 Roth Capital Partners Growth Stock Conference PORTLAND, Ore.--BW HealthWire--Feb. 19, 2002 AVI BioPharma Inc. (Nasdaq:AVII) (Nasdaq:AVIIW) (Nasdaq:AVIIZ) today announced that company executives will speak at two prominent investor and biotechnology conferences this week. AVI's President...
- Research articles 2002-02-19
- China Biopharma, Inc. Retains The Global Consulting Group As Investor Relations Counsel
- PRINCETON, N.J. -- China Biopharma, Inc. (OTCBB: TEDG) has retained The Global Consulting Group, a strategic consulting firm headquartered in New York, to provide investor relations and financial communications counsel.
- Research articles 2006-08-15
- China Biopharma Week in Review: Broad Views, Individual Companies
- ChinaBio Today submits: In ChinaBio Today over the past five days, we featured three broad overviews of the China biomedical world, each sourced from an outside publication. The news these articles imparted may seem familiar to our regular readers, who are very aware of the transformation taking place in...
- External links 2008-09-14
- PDL BioPharma Inc. Q3 2008 Earnings Call Transcript
- Earnings Call ExcerptPDL BioPharma Inc. PDLI Q3 2008 Earnings Call November 6, 2008 4:30 pm ET Executives Ami Knoefler - Head of Corporate and IR Dr. Mark McCamish - Senior Vice President and Chief Medical Officer Faheem Hasnain – President and CEO Andrew Guggenhime - CFO ...
- Earnings calls 2008-11-06
- AVI BioPharma Receives DoD Contracts for Bioterrorism Response Therapies.
- M2 PRESSWIRE-7 May 2007-ExploratioinInvestor.com: AVI BioPharma Receives DoD Contracts for Bioterrorism Response TherapiesC1994-2007 M2 COMMUNICATIONS LTD RDATE:07052007 Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your small and large...
- Research articles 2007-05-07
- BWR initiates research on AVI BioPharma Inc.
- M2 PRESSWIRE-29 October 2004-bellwetherreport.com: BWR initiates research on AVI BioPharma IncC1994-2004 M2 COMMUNICATIONS LTD RDATE:10292004 Bellwether Report issues aggressive investor alert for AVI Biopharma Inc (Nasdaq:AVII), an emerging biopharmaceutical company and a pioneer in the development of therapeutic products based upon...
- Research articles 2004-10-29
- Kosan Insiders Purchase Additional Shares From Early Investor
- Business Editors and Health/Medical Writers HAYWARD, Calif.--BW HealthWire--April 24, 2001 Kosan Biosciences Incorporated (Nasdaq:KOSN) announced today that its Chairman and CEO and funds affiliated with Alta Partners have purchased the entire stock position of a pre-IPO investor in Kosan. The 1,502,931 shares of unregistered Common Stock were purchased...
- Research articles 2001-04-24
- Weyerhaeuser Wins Best of Show at NIRI Seattle's Investor Communications Awards Gala
- SEATTLE -- The Seattle Chapter of the National Investor Relations Institute NIRI announced today that Weyerhaeuser's 2007 annual report won "Best of Show" at the 2008 Investor Communications Awards Gala held June 26. Seattle Genetics won Best in Show among Biopharma/Healthcare entries, a new category this year. Twenty-one Northwest...
- Research articles 2008-06-27
- Crucell Presents a Compelling Case for Investment at Investor and Analyst Day in London
- London, March 12, 2008 - Dutch biopharma company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: SW CRX) today presents an update on the company's performance, strategy for growth acceleration and a review of the company's pipeline at a meeting...
- Research articles 2008-03-12
- PerkinElmer Inc. Q3 2008 Earnings Conference Call Transcript
- Question-and-Answer Session[Operator Instructions]. Michael A. Lawless - Investor Relations Hello, operator, we may be having some technical difficulties. We are not hearing any questions on our end. Operator Please stand by. Your first question comes from the line of Vivek Khanna. Please proceed. Unidentified Analyst Hello, can you hear...
- Earnings calls 2008-10-23
- << Previous
- page 1 of 1
- Next >>
